These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 27038440)

  • 1. A phase I randomized trial to assess the effect on skin infiltrate thickness and tolerability of topical phosphodiesterase inhibitors in the treatment of psoriasis vulgaris using a modified psoriasis plaque test.
    Snape SD; Wigger-Alberti W; Goehring UM
    Br J Dermatol; 2016 Sep; 175(3):479-86. PubMed ID: 27038440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roflumilast Cream Improves Signs and Symptoms of Plaque Psoriasis: Results from a Phase 1/2a Randomized, Controlled Study.
    Papp KA; Gooderham M; Droege M; Merritt C; Osborne DW; Berk DR; Thurston AW; Smith VH; Welgus H
    J Drugs Dermatol; 2020 Aug; 19(8):734-740. PubMed ID: 32845114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial of Roflumilast Cream for Chronic Plaque Psoriasis.
    Lebwohl MG; Papp KA; Stein Gold L; Gooderham MJ; Kircik LH; Draelos ZD; Kempers SE; Zirwas M; Smith K; Osborne DW; Trotman ML; Navale L; Merritt C; Berk DR; Welgus H;
    N Engl J Med; 2020 Jul; 383(3):229-239. PubMed ID: 32668113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.
    Lebwohl MG; Kircik LH; Moore AY; Stein Gold L; Draelos ZD; Gooderham MJ; Papp KA; Bagel J; Bhatia N; Del Rosso JQ; Ferris LK; Green LJ; Hebert AA; Jones T; Kempers SE; Pariser DM; Yamauchi PS; Zirwas M; Albrecht L; Devani AR; Lomaga M; Feng A; Snyder S; Burnett P; Higham RC; Berk DR
    JAMA; 2022 Sep; 328(11):1073-1084. PubMed ID: 36125472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial.
    Stein Gold L; Adam DN; Albrecht L; Alonso-Llamazares J; Ferris LK; Gooderham MJ; Hong HC; Kempers SE; Kircik LH; Lebwohl M; Loo WJ; Nahm WK; Papp KA; Stewart D; Toth DP; Zirwas M; Krupa D; Snyder S; Burnett P; Higham R; Berk DR
    J Am Acad Dermatol; 2024 Aug; 91(2):273-280. PubMed ID: 38556093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
    Molin L; Cutler TP; Helander I; Nyfors B; Downes N
    Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the safety and efficacy of tapinarof and roflumilast topical therapies in the management of mild-to-moderate plaque psoriasis.
    Ghani H; Podwojniak A; Tan IJ; Parikh AK; Sanabria B; Rao B
    Skin Res Technol; 2024 Sep; 30(9):e70041. PubMed ID: 39206797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roflumilast Cream vs Vehicle Cream and Chronic Plaque Psoriasis.
    Smith B; Collier MR; Wu JJ
    JAMA; 2023 Feb; 329(7):594-595. PubMed ID: 36809326
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and Safety of Topical Roflumilast for the Treatment of Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    de Moraes-Souza R; Chahine Chater R; Pera Calvi I; Mesquita Y; Sarto R; Lapenda I; Figueiredo Pereira L; Moury L; Herranz-Pinto P
    Clin Drug Investig; 2024 Sep; 44(9):655-665. PubMed ID: 39172296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roflumilast Cream vs Vehicle Cream and Chronic Plaque Psoriasis-Reply.
    Lebwohl MG; Hebert AA; Gooderham MJ
    JAMA; 2023 Feb; 329(7):595. PubMed ID: 36809324
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III study.
    Naldi L; Yawalkar N; Kaszuba A; Ortonne JP; Morelli P; Rovati S; Mautone G
    Am J Clin Dermatol; 2011 Jun; 12(3):191-201. PubMed ID: 21284407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roflumilast 0.3% Cream: a Phosphodiesterase 4 Inhibitor for the Treatment of Chronic Plaque Psoriasis.
    Nicolas SE; Bear MD; Kanaan AO; Coman OA; Dima L
    Am J Ther; 2023 Nov-Dec 01; 30(6):e535-e542. PubMed ID: 37921681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of Roflumilast Cream in Chronic Plaque Psoriasis: Data from Phase I to Phase III Studies.
    Thurston AW; Osborne DW; Snyder S; Higham RC; Burnett P; Berk DR
    Am J Clin Dermatol; 2023 Mar; 24(2):315-324. PubMed ID: 36422852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
    Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
    Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical Roflumilast for Plaque Psoriasis.
    O'Toole A; Gooderham M
    Skin Therapy Lett; 2023 Sep; 28(5):1-4. PubMed ID: 37734074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral roflumilast therapy on body weight and cardiometabolic parameters in patients with psoriasis - results from a randomized controlled trial (PSORRO).
    Gyldenløve M; Sørensen JA; Fage S; Meteran H; Skov L; Zachariae C; Knop FK; Nielsen ML; Egeberg A
    J Am Acad Dermatol; 2024 Jul; 91(1):64-71. PubMed ID: 38431099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcipotriol ointment versus cream in psoriasis vulgaris.
    Duweb G; Aldebani S; Elzorghany A; Benghazil M; Alhaddar J
    Int J Clin Pharmacol Res; 2003; 23(2-3):47-51. PubMed ID: 15018018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy.
    Kragballe K; Barnes L; Hamberg KJ; Hutchinson P; Murphy F; Møller S; Ruzicka T; Van De Kerkhof PC
    Br J Dermatol; 1998 Oct; 139(4):649-54. PubMed ID: 9892908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the antipsoriatic effect and tolerability of calcipotriol-containing products in the treatment of psoriasis vulgaris using a modified psoriasis plaque test.
    Queille-Roussel C; Hoffmann V; Ganslandt C; Hansen KK
    Clin Drug Investig; 2012 Sep; 32(9):613-9. PubMed ID: 22845045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.